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Abstract
AIM: To investigate gene variants in a large Italian 
inflammatory bowel disease (IBD) cohort, and to 
analyze the correlation of sub-phenotypes (including 
age at diagnosis) and epistatic interaction with other 
IBD genes.
METHODS: Total of 763 patients with Crohn’s 
disease (CD, 189 diagnosed at age < 19 years), 
843 with ulcerative colitis (UC, 179 diagnosed < 
19 years), 749 healthy controls, and 546 healthy 
parents (273 trios) were included in the study. The 
rs2241880 [autophagy-related 16-like 1  (ATG16L1 )], 
rs11209026 and rs7517847 [interleukin 23 receptor  
(IL23R)], rs2066844, rs2066845, rs2066847 (CARD15), 
rs1050152 (OCTN1 ), and rs2631367 (OCTN2 ) gene 
variants were genotyped.
RESULTS: The frequency of G allele of ATG16L1  
SNP (Ala197Thr) was increased in patients with CD 
compared with controls (59% vs  54% respectively) 
(OR = 1.25, CI = 1.08-1.45, P  = 0.003), but not in 
UC (55%). The frequency of A and G (minor) alleles 
of Arg381Gln, rs11209026 and rs7517847 variants of 
IL23R  were reduced significantly in CD (4%, OR = 
0.62, CI = 0.45-0.87, P  = 0.005; 28%, OR = 0.64, CI 
= 0.55-0.75, P  < 0.01), compared with controls (6% 
and 38%, respectively). The A allele (but not G) was 
also reduced significantly in UC (4%, OR = 0.69, CI = 
0.5-0.94, P  = 0.019). No association was demonstrated 
with sub-phenotypes and interaction with CARD15 , 
and OCTN1/2  genes, although both gene variants were 
associated with pediatric-onset disease.
CONCLUSION: The present study confirms the 
association of IL23R  polymorphisms with IBD, and 
ATG16L1  with CD, in both adult- and pediatric-onset 
subsets in our study population.
© 2008 The WJG Press. All rights reserved.
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INTRODUCTION
Inflammatory bowel disease (IBD) is a polygenic trait 
that includes two similar, yet distinct conditions, namely 
Crohn’s disease (CD) and ulcerative colitis (UC)[1]. It 
is widely accepted that both diseases result from an 
inappropriate response of  a defective mucosal immune 
system to indigenous flora and other luminal agents in a 
genetically susceptible host[2].
Eleven IBD genome-wide linkage analyses in families 
with multiple IBD affected members, as well as two 
different meta-analyses[3,4] have identified several linkage 
regions[5]. Following the identification of  NOD2 (or 
CARD15), the first gene contributing to CD susceptibility 
(IBD1 locus), further fine mapping studies have identified 
a risk haplotype (IBD5 locus) on chromosome 5q[6], 
along with two polymorphisms in the solute carrier family 
22A4/22A5 (SLC22A4/A5) coding for OCTN1 and 
OCTN2, suggested as candidate genes[7], and another 
polymorphism on the disk large homolog 5 (DLG5) gene[8]. 
However, these risk-associated variants and several others 
reported[9-13] with conflicting results, explain only a minor 
component of  the genetic risk in IBD.
Whole genome association (GWA) studies in IBD 
have rapidly led to the identification of  novel susceptibility 
loci associated with CD[14], such as interleukin-23 receptor 
(IL23R) and autophagy-related 16-like 1 gene (ATG16L1). 
An uncommon coding mutation (rs11209026) in the 
IL23R gene[15] on chromosome 1 (1p32.1-p31-2), a 
G-to-A transition at nucleotide 1142 (Arg381Gln), has 
been identified to confer strong protection against CD in 
case-control (P = 5.05 × 10-9) and family-based studies 
of  Caucasian and Jewish cohorts with ileal CD. Further, 
GWA[16-19] and replication studies[1,2] have consistently 
confirmed strong association between variations at IL23R 
and CD. The intronic rs7517847 SNP (single nucleotide 
polymorphism) gave the most significant signal (P = 
3.36 × 10-13)[15]. The association of  this variant appeared 
statistically independent from Arg381Gln and not in 
linkage disequilibrium (r2 = 0.03)[15]. A large number 
of  replications in adult-[20-24] and pediatric-onset[25-29] 
cohorts have been reported, but no significant association 
with specific CD sub-phenotype has been identified. 
Moreover, an association with UC has also been 
observed[23,24,28,30,31].
In a recent Ger man GWA scan [32], the non-
synonymous rs2241880 (Ala197Thr) var iant of  
ATG16L1 on chromosome 2p37.1 was found to be 
associated with CD, and appeared to account for all of  
the disease risk conferred by this locus. This association 
has been consistently demonstrated in a number of  
independent studies in adult[24,33-36] but with conflicting 
data in pediatric[34,37,38] IBD cohorts. 
The aims of  the present study were to investigate 
the association between variants of  two candidate genes 
IL23R and ATG16L1 and IBD in an Italian cohort. 
In addition, we examined the genotype-phenotype 
correlation with specific disease subtypes, including 
the early onset of  disease, and the possible genetic 
interactions with OCTN1/2, and CARD15 genes.
MATERIALS AND METHODS
Materials
The study population included 763 CD and 843 UC 
unrelated patients recruited from four referral centers 
for adult IBD: the “Casa Sollievo della Sofferenza” Hospital 
of  San Giovanni Rotondo, and the University Hospitals 
of  Padua, Naples and Milan. In addition, 368 patients 
with pediatric onset of  disease (age at diagnosis < 
19 years) were included in the study because of  a 
multi-center effort of  the Italian Society of  Pediatric 
Gastroenterology, Hepatology and Nutrition (SIGENP). 
This study cohort has been reported elsewhere[39]. Two 
hundred and seventy-three IBD patients also had both 
parents available for the purpose of  a family-based 
analysis. The 749 healthy controls (415 male, mean age 
43 ± 11 years, range 22-75) were randomly recruited 
from three sites: San Giovanni Rotondo (Southern Italy, 
n = 451), Rome (Central Italy, n = 114) and Milano 
(Northern Italy, n = 184), in order to minimize potential 
geographic heterogeneity. These subjects comprised 
of  unrelated, asymptomatic individuals (blood donors, 
students, and staff  members), all Caucasians with no 
Jewish descent. The study protocol was approved by the 
local Ethics Committees, and a written informed consent 
was obtained from each subject (or parents). 
Demographic and sub-phenotype data of  IBD 
patients are presented on Table 1. The diagnosis of  CD 
and UC was established according to accepted clinical, 
endoscopic, radiological, and histological criteria[1]. The 
Montreal[40] classification was used for CD, based on the 
age at diagnosis (A), location (L), and disease behavior 
(B). In patients with UC, the disease location was 
categorized according to the Montreal classification, by 
distinguishing ulcerative proctitis (E1), left-side colitis (E2), 
and extensive colitis (E3). Patients with indeterminate 
colitis were excluded from the study. In all patients, the 
following clinical features were recorded: family history, 
age at diagnosis, duration of  follow-up, presence of  
perianal fistulae, extraintestinal manifestations (presence 
or absence of  any extraintestinal manifestation), previous 
abdominal surgery (either colectomy in UC or bowel 
resection in CD), and smoking habit (at least 1 cigarette/d). 
To account for the known modification of  clinical 
characteristics during the disease course, only patients 
with at least two years of  follow-up from the time of  
a confirmed diagnosis were included in the genotype/
phenotype analysis.
Methods
Genotyping of  rs11209026 (IL23R ) , rs7517847 
(IL23R), rs2241880 (ATG16L1), rs10150152 (OCTN1) 
and rs2631367 (OCTN2) [41] SNPs was performed 
us ing Appl ied Biosys tems 7700 TaqMan assay 
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(Applied Biosystems, Foster City, CA). The CARD15 
variants were detected by means of  Denaturing High 
Performance Liquid Chromatography (DHPLC)(Wave 
System, Transgenomic Ltd, UK)(R702W, L1007fsinsC) 
and RFLP (G908R) , respect ive ly, as descr ibed 
previously[39]. PCR reactions were carried out in 96-well 
plates on ABI 9700 Thermocyclers (Applied Biosystems, 
Foster City, CA). All samples were genotyped at the 
Molecular Laboratory of  Gastroenterology Unit in San 
Giovanni Rotondo Hospital, Italy.
For the purpose of  statistical analysis, after genotyping 
the markers, the Hardy-Weinberg equilibrium was tested 
by comparing the expected and observed genotypes in 
2 × 3 χ2 tables. All markers showed no deviation from 
the Hardy-Weinberg equilibrium in controls (P > 0.05). 
Allele-genotype frequencies and genotype/phenotype 
association were analysed by χ2 and Fisher exact tests, when 
appropriate, by the SPSS software ver 1.5. The Hardy-
Weinberg equilibrium and marker linkage disequilibrium 
analysis were also performed by the Arlequin software ver 
2.0. Pairwise SNP linkage disequilibrium (LD) coefficients, 
haplotype frequencies, and Transmission Disequilibrium 
Test (TDT) were estimated using Haploview[42]. Logistic 
regression analysis was used to assess the conditional 
independence between genotypes and IBD phenotypes and 
to test for gene-gene interactions. The frequencies and odds 
ratios of  individual CARD15 genotypes were stratified by 
ATG16L1 (rs2241880) and IL23R (rs1209026); and IL23R 
genotypes were stratified by ATG16L1 genotypes. An 
interaction was considered significant at P < 0.05.
RESULTS 
Patients and controls
A total of  2901 subjects were investigated. These 
comprised of  763 patients with CD (435 males and 328 
females), with a mean age at diagnosis of  29 years (range 
1-79), and 843 patients with UC (492 males, 351 female), 
with a mean age at diagnosis of  32 years (range 1-76 
years). In addition, 749 healthy controls and 546 healthy 
parents were also evaluated. Of  note, 368 patients (180 
male) were diagnosed at the age of  18 years or less.
Genotyping of ATG16L1 variant in IBD patients
The evaluation of  the T300A polymorphism (rs2241880) 
was available in 667 CD and 668 UC patients: the 
frequency of  the G allele was increased in CD patients 
compared with controls (59% vs 54%) (P = 0.003, OR = 
1.25, CI = 1.08-1.45) (Table 2). Accordingly, by comparing 
genotype frequencies (Table 2), a significant increase 
in carriers of  G risk allele was found in CD patients 
compared to controls (84% vs 79%) (P = 0.008, OR = 1.44, 
CI = 1.10-1.89). After stratifying the CD cohorts on the 
basis of  age at diagnosis (adult ≥ 19 years; pediatric < 19 
years), the allele/genotype difference remained significant 
only in the adult subgroup (P = 0.004), perhaps due to the 
small sample size of  the pediatric subgroup, although the 
frequencies were similar.
There was no significant difference in the allele and 
genotype frequencies between UC patients and controls 
for the groups as a whole and after stratifying on the 
basis of  pediatric and adult age at diagnosis.
Genotyping of IL23R variants in IBD patients
A total of  723 CD, 804 UC, and 716 controls were 
genotyped for the rs7517847 polymorphism. The minor 
allele (G) frequency was significantly reduced (28%) in 
CD cases compared with controls (38%) (P < 0.01, OR 
= 0.64, CI = 0.55-0.75), with a significant reduction in 
carriers (49% vs 61% in controls) (P < 0.01, OR = 0.63, 
CI = 0.51-0.77) (Table 2). These differences remained 
significant after stratification of  the patients on the basis 
of  age at diagnosis. In contrast, no significant difference 
in allele and genotype frequencies was found in UC 
patients (Table 2). 
A total of  735 CD and 823 UC patients, and 726 
healthy controls were genotyped for rs11209026 
polymorphism. The minor allele frequency (A) in CD 
patients was 4%, compared with 6% in controls, yielding 
a protective OR of  0.62 (CI = 0.45-0.87; P = 0.005) 
(Table 2). Compared with controls (87%), the frequency 
of  the risk genotype was significantly increased in CD 
patients (92%) (P = 0.005, OR = 0.61, CI = 0.43-0.86). 
These differences resulted in similar statistical significance 
after stratifying CD patients on the basis of  age at 
diagnosis. 
In addition, a high significant association was also 
found in UC patients, with a similar MAF frequency (4%) 
leading to a protective OR of  0.69 (CI = 0.50-0.94; P = 
0.019). Accordingly, the frequency of  GG genotype was 
also significantly increased in UC patients (91%, P = 0.015) 
Table 1  Demographic and clinical features of CD and UC 
according to the Montreal classification[39]
CD (n  = 763) UC (n  = 843)
Sex (M/F) 435/328 492/351
Duration of follow-up, mean  ±  SD 
(range)
8 ± 7 (1-37) 9 ± 7 (1-41)
Age at diagnosis (yr), mean  ±  SD 
(range)
29 ± 15 (1-79) 32 ± 16 (1-76)
   ≤ 16 (A1) 173 (22%) 155 (18%)
   17-40 (A2) 431 (57%) 458 (55%)
   > 40 (A3) 159 (21%) 230 (27%)
Disease localization CD, n (%)
   Ileum (L1 ± L4) 241 (31%)
   Colon (L2 ± L4) 200 (26%)
   Ileo-colon (L3 ± L4) 315 (41%)
   Upper GI (L4)   7 (2%)
Disease extent UC, n (%) 
   Rectum (E1) 102 (13%)
   Left colon (E2) 416 (49%)
   Pancolitis (E3) 325 (38%)
Disease behavior CD, n (%)
   Inflammatory (B1 ± p) 346 (46%)
   Stricturing (B2 ± p) 177 (23%)
   Penetrating (B3 ± p) 240 (31%)
Perianal disease y/n (%) 137/626 (18%) 17/826 (2%)
Smoking history 
   Yes 242 (33%) 119 (15%)
   No 423 (55%) 510 (60%)
   Ex   98 (12%) 214 (25%)
Family history of IBD y/n (%)   74/689 (10%) 53/790 (6%)
Surgery y/n, n (%) 237/526 (31%)   95/748 (13%)
Extra-intestinal manifestations y/n (%) 304/459 (40%) 182/661 (21%)
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(Table 2). These statistical differences remained after 
stratifying the cohort on the basis of  age at diagnosis.
Haplotype association analysis of  two IL23R variants, 
rs7517847 and rs11209026, was also estimated (Table 3). 
An increase in TG haplotype frequency was observed in 
IBD (68%, P = 0.0032) and CD patients (71%, P ≤ 0.01), 
compared with controls (62%).
Family-based analysis
Given the lack of  a significant association of  allele/
genotype frequencies of  the ATG16L1 gene in the 
pediatric subset, and the availability of  273 pediatric 
IBD Tr ios (138 CD, and 135 UC) , the T300A 
polymorphism was tested by transmission disequilibrium 
test; a significant over-transmission of  the G allele was 
found in CD patients (T:U = 90:62; P = 0.023), but not 
in UC (Table 4). With respect to IL23R, a significant 
over-transmission of  the T allele of  rs7517847 (T:U = 
137:101), and the G allele of  rs11209026 (T:U = 34:19) 
SNPs was observed in the whole IBD cohort (P = 0.0196, 
P = 0.0394; respectively), and more specifically in CD 
patients (P = 0.0015, P = 0.0833, respectively). However, 
the results in the UC subset did not reach statistical 
significance. An association between the rs7517847-
rs11209026 (TG) haplotype and IBD, CD, and UC was 
also tested using the TDT. Consistent evidence of  over-
transmission of  this haplotype in the whole IBD cohorts 
(T:U = 141:100, P = 0.0084) was maintained (Table 4).
Genotype/phenotype correlation
Analysis of  the allele and genotype frequencies of  the 
rs2241880 SNP of  the ATG16L1 gene, showed no 
association with disease location, behaviour, and age 
at diagnosis based on the Montreal classification of  
CD cases (Table 5). More specifically, we observed the 
lowest frequency of  the G allele in isolated colonic 
disease (55%), increasing to 60% in ileal and ileo-colonic 
disease, without a clear difference in adult and pediatric 
subsets (colonic disease: adult 55%, pediatric 54%). 
Similarly, there was no association with gender, smoking 
history, perianal fistulae, and presence of  extra-intestinal 
manifestations. Moreover, no association was found with 
any specific sub-phenotypes of  UC (Table 6). 
Similarly, there was no correlation between risk 
Table 2  Genotypes and alleles distribution for ATG16L1 and IL23R SNPS in CD, UC and controls 
Genotypes Alleles
AA Aa aa Total P OR (95% CI) Freq P OR (95% CI)
ATG16L1
rs2241880 (AA Aa vs aa) G
   CD Total 227 (34%) 335 (50%) 105 (16%) 667 0.008 1.44 (1.10-1.89) 0.59 0.003 1.25 (1.08-1.45)
   CD adult 165 (34%) 254 (52%)   72 (15%) 491 0.004 1.57 (1.16-2.13) 0.59 0.004 1.27 (1.08-1.49)
   CD pediatric   62 (35%)   81 (46%)   33 (19%) 176 0.466 1.17 (0.77-1.77) 0.58 0.122 1.20 (0.95-1.52)
   UC Total 212 (32%) 315 (47%) 141 (21%) 668 0.956 1.01 (0.78-1.30) 0.55 0.381 1.07 (0.92-1.24)
   UC adult 157 (31%) 244 (48%) 105 (21%) 506 0.839 1.03 (0.78-1.36) 0.55 0.469 1.06 (0.90-1.25)
   UC pediatric   55 (34%)   71 (44%)   36 (22%) 162 0.779 0.94 (0.63-1.42) 0.56 0.473 1.09 (0.86-1.39)
   Controls 214 (29%) 376 (50%) 159 (21%) 749 - 0.54
IL23R
rs7517847 (Aa aa vs AA) G
   CD Total 366 (51%) 305 (42%) 52 (7%) 723       < 0.01 0.63 (0.51-0.77) 0.28    < 0.01 0.64 (0.55-0.75)
   CD adult 273 (51%) 225 (42%) 42 (8%) 540       < 0.01 0.63 (0.50-0.79) 0.29    < 0.01 0.65 (0.55-0.78)
   CD pediatric   93 (51%)   80 (44%) 10 (5%) 183       < 0.01 0.62 (0.45-0.86) 0.27    < 0.01 0.61 (0.48-0.79)
   UC Total 326 (41%) 390 (49%)   88 (11%) 804 0.567 0.94 (0.77-1.16) 0.35 0.111 0.89 (0.76-1.03)
   UC adult 259 (41%) 301 (48%)   71 (11%) 631 0.468 0.92 (0.74-1.15) 0.35 0.121 0.88 (0.75-1.03)
   UC pediatric   67 (39%)   89 (51%)   17 (10%) 173 0.927 1.02 (0.72-1.43) 0.36 0.400 0.90 (0.70-1.15)
   Controls 280 (39%) 328 (46%) 108 (15%) 716 - 0.38
rs11209026 A
   CD Total 675 (92%) 60 (8%)   0 (0%) 735 0.005 0.61 (0.43-0.86) 0.04 0.005 0.62 (0.45-0.87)
   CD adult 502 (91%) 50 (9%)   0 (0%) 552 0.042 0.69 (0.48-0.99) 0.05 0.041 0.69 (0.49-0.99)
   CD pediatric 173 (95%) 10 (5%)   0 (0%) 183 0.006 0.40 (0.20-0.78) 0.03 0.007 0.41 (0.21-0.80)
   UC Total 750 (91%) 72 (9%)   1 (0%) 823 0.015   0.67 (0.48 - 0.93) 0.04  0.019 0.69 (0.50-0.94)
   UC adult 589 (91%) 58 (9%)   1(0%) 648 0.035 0.69 (0.49-0.98) 0.05 0.043 0.71 (0.51-0.99)
   UC pediatric 161 (92%) 14 (8%)   0 (0%) 175 0.085 0.60 (0.33-1.08) 0.04 0.087 0.61 (0.34-1.08)
   Controls 634 (87%)   91 (13%)   1 (0%) 726 - 0.06
“A” refers to wild type and “a” to mutated allele. Adult and pediatric subgroups are divided on the basis of the age at diagnosis (≥ 19 years and < 19 years, 
respectively).
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Table 3  Haplotypes frequency of he two IL23R variants in IBD patients and controls
Haplotype IBD CD UC
rs7517847 rs11209026  Cases/Controls (% Haplotype) P Cases/Controls (% Haplotype) P Cases/Controls (% Haplotype) P
T G 68/62 0.0032 71/62 < 0.01 65/62 0.2166
G G 28/32 0.0548 25/32 < 0.01 31/32 0.7398
G A 4/6 0.0121 4/6         0.0088 4/6 0.0578
alleles and genotypes of  the IL23R genes with specific 
sub-phenotypes of  CD (Table 5) and UC (Table 6). Of  
note, the frequency of  A allele of  rs11209026 was the 
lowest in patients diagnosed at < 16 years of  age (2.8%), 
increasing to 3.6% in the age group of  17-40 years, and 
6.7% in those over 40 years, but the differences did not 
reach statistical significance (Table 5). More specifically, 
despite the large number of  pediatric onset IBD patients 
investigated, genotype/phenotype frequencies were similar 
after further stratifying IBD population into adult and 
pediatric age of  onset of  the disease (data not shown). 
Interaction between ATG16L1, IL23R, CARD15, 
and OCTN1/2 genes
Logistic regression analysis was used to evaluate the 
individual contributions of  CARD15 (at least 1 variant 
against wild type), ATG16L1 (GG/AG vs AA), IL23R 
rs11209026 (AG/AA vs GG) and OCTN (diplotype 
TTCC against the rest) and CD risk, and to test for 
statistical interaction. The analysis included 763 CD 
cases and 749 controls. Table 7 shows the results 
of  the logistic regression model with the individual 
contributions of  CARD15, ATG16L1, IL23R, and 
OCTN to disease risk, their contribution after adjustment 
for CARD15 genotype, and the contribution of  
interactions with CARD15. The individual contribution 
of  all the predisposing genes was confirmed. By contrast, 
there was no evidence of  a statistical interaction between 
all loci (P = 0.428), and ATG16L1, IL23R, and OCTN 
by pairs and triplets (data not showed).
DISCUSSION
With the recent introduction of  the GWA technology, 
Table 4  Transmission disequilibrium test (TDT) for rs7517847 and rs11209026 IL23R SNPs for IBD, CD, and UC
Marker Over-trans Haplotype IBD (n  = 273) CD (n  = 138) UC (n  = 135)
T U P T U P T U P
rs7517847 T 137 101 0.0196 74 40 0.0015 63 61 0.8575
rs11209026 G   34   19 0.0394 18   9 0.0833 16 10 0.2393
TG 141 100 0.0084 52 60 0.0012 45 34 0.5947
GG   97 123 0.0790 50 39 0.0098 28 28 0.9940
GA   14   24 0.1088 12 20 0.0585   9 13 0.6555
TA     5   10 0.1831 13   8 0.7037 - - -
rs2241880 G - - - 90 62 0.0231 - - -
TDT haplotypes are also included. Data of over-transmitted allele are given, with counts of transmitted (T) and un-transmitted (U) alleles.
Table 5  Genotype and allele frequency distribution of ATG16L1 and IL23R  SNPs in CD cases stratified by phenotypic subgroups, (n)
SNP/gene genotype rs2241880  ATG16L1 rs7517847  IL23R rs11209026  IL23R
AA 
(105)
AG
(335)
GG
(227)
Total
(667)
Freq (G) 
0.501
GG
(52)
GT
(305)
TT
(366)
Total
(723)
Freq (G) 
0.283
AA
(0)
AG
(60)
GG
(675)
Total 
(735)
Freq (A) 
0.041
Sex     
   Male 54 193 126 373 0.597 28 169 212 409 0.275 0 27 390 417 0.032
   Female 51 142 101 294 0.585 24 136 154 314 0.293 0 33 285 318 0.052
Age at diagnosis (yr)    
   ≤ 16 (A1) 28   72   53 153 0.582   9   76   74 159 0.296  0   9 150 159 0.028
   17-40 (A2) 56 180 123 359 0.593 24 160 209 393 0.265  0 29 378 407 0.036
   > 40 (A3) 20   71   40 131 0.576 14   57   73 144 0.295  0 19 123 142 0.067
Disease localization    
   Ileum (L1 ± L4) 28   97   67 192 0.602 12   86 118 216 0.255  0 21 200 221 0.048
   Colon (L2 ± L4)  31   92   48 171 0.550 10   76 104 190 0.253  0 18 170 188 0.048
   Ileo-colon (L3 ± L4) 43 131 101 275 0.605 25 131 129 285 0.318  0 19 276 295 0.032
   Upper GI (L4)   2     4     1     7 0.429   0     2    4     6 0.167  0   0     6     6 0.000
Disease behavior    
   Inflammatory (B1) 44 154   98 296 0.591 21 133 162 316 0.277  0 25 294 319 0.039
   Stricturing (B2) 22   79   46 147 0.582 10   64   82 156 0.269  0 16 145 161 0.050
   Penetrating (B3) 38   85   70 193 0.583 17   93 103 213 0.298  0 17 201 218 0.039
Perianal disease     
   Yes 14   52   37 103 0.612   8   54   59 121 0.289  0 11 113 124 0.044
   No 89 269 175 533 0.581 40 233 293 566 0.277  0 46 529 575 0.040
Smoking history    
   No 57 168 116 341 0.587 24 149 191 364 0.271  0 29 339 368 0.039
   Yes 32 105   71 208 0.594 20 100 107 227 0.308  0 20 213 233 0.043
   Ex 14   39   30   83 0.596   3   41   49   93 0.253  0   8   88   96 0.042
Surgery    
   Yes 34   91   68 193 0.588 15   83 113 211 0.268  0 16 202 218 0.037
   No 70 231 149 450 0.588 32 211 241 484 0.284  0 42 447 489 0.043
Only patients with at least 2 years of follow-up from diagnosis were included.
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several novel genes and loci involved in the pathogenesis 
of  IBD have been uncovered, as well as the successful 
identification and replication of  multiple susceptibility 
genes for CD[11,15,18,20,21,32], such as IL23R and ATG16L1. 
However, these genetic variations account for only a small 
portion of  the overall genetic susceptibility to CD, and their 
contribution to the pathogenesis of  UC is even lower.
T h e p r e s e n t s t u d y c o n f i r m s t h e r e p o r t e d 
association between IL23R and ATG16L1 variants and 
susceptibility to CD, both in the case-control and family-
based analysis, and in both adult- and pediatric-onset 
disease. Moreover, we also replicated the significant 
association between the rs11209026 variant of  IL23R 
and UC (P = 0.018), suggesting that this gene may also 
have a role in the genetic susceptibility to UC. Although 
the size of  the cohort was sufficiently large, consisting 
of  more than 1600 IBD patients, we were unable to 
detect an association between IL23R and ATG16L1 
variants and any sub-phenotypes for both diseases, as 
described in the majority of  published studies, thus 
suggesting that the overall effect of  these variants on 
certain CD subtypes[22,23,31,34-36,38] is much weaker than that 
observed in CARD15. Moreover, we found no statistical 
evidence for epistatic interaction between IL23R, 
ATG16L1, OCTN1/2, and CARD15 genes. Since our 
cohort also included a large number of  pediatric cases 
(368 diagnosed at age < 19 years), this study confirmed 
that the rs2241880 polymorphism in the ATG16L1[34,37] 
gene and the rs7517847, rs11209026 polymorphisms in 
the IL23R gene[22,25,27-30] also influence susceptibility to 
CD in pediatric-onset patients, at allele and genotype 
frequencies comparable to that seen in adults.
Recent studies have reported genotype-phenotype 
associations in adult-pediatric onset CD and ATG16L1 
Ala197Thr variant. Specifical ly, Prescott e t a l [34] 
demonstrated an association with ileal form of  CD with 
or without colonic involvement (61.7%) but not with 
isolated colonic disease (52.2%), as well as with diagnosis 
at an earlier age (≤ 16 years at diagnosis: 63.8%). 
Subsequently, van Limbergen et al[38] confirmed the 
association of  isolated ileal disease with rs2241880G-
allele (P = 0.02) in a combined genotype-phenotype 
analysis of  early and adult onset CD, although after 
stratifying CD cases in early- and adult-onset the 
association did not reach statistical significance (P = 0.28 
and P = 0.08, respectively), probably due to the reduced 
power of  the sample sizes.
We observed rs2144880G variant allele frequency of  
55% in colonic disease (L2 ± L4), which increased to 
60% in pure ileal disease (L1 ± L4), without significant 
Table 6  Genotype and allele frequencies of ATG16L1 and IL23R  SNPs in UC cases stratified by phenotypic subgroups, (n)
SNP/gene genotype rs2241880  ATG16L1 rs7517847  IL23R rs11209026  IL23R
AA
(141)
AG
(315)
GG
(212)
Total
(668)
Freq (G) 
0.553
GG
(88)
GT
(390)
TT
(326)
Total
(804)
Freq (G) 
0.352
AA
(1)
AG
(72)
GG
(750)
Total
(823)
Freq (A) 
0.045
Sex     
   Male 77 183 112 372 0.547 41 236 185 462 0.344 0 45 432 477 0.047
   Female 64 132 100 296 0.561 47 154 141 342 0.363 1 27 318 346 0.042
Age at diagnosis (yr)  
   ≤ 16 (A1) 30 58   48 136 0.566 15   76   49 140 0.379 0 11 129 140 0.039
   17-40 (A2) 79 159 102 340 0.534 40 213 170 423 0.346 0 33 401 434 0.038
   > 40 (A3) 24   84   55 163 0.595 28   86   89 203 0.350 1 25 184 210 0.064
Disease localization  
   Rectum 18   41   15   74 0.480 13   38   39   90 0.356 1   8   80   89 0.056
   Rectum-sigmoid 20   55   39 114 0.583 20   82   46 148 0.412 0 21 134 155 0.068
   Left colon 41 101   64 206 0.556 27 104 100 231 0.342 0 19 215 234 0.041
   Colon 54 104   86 244 0.566 24 148 124 296 0.331 0 22 283 305 0.036
Perianal disease  
   Yes   3     3     6   12 0.625   0     6    8   14 0.214 0   2   13   15 0.067
   No    129 298 198 625 0.555 82 367 301 750 0.354 1 67 699 767 0.045
Smoking history
   No 81 173 125 379 0.558 51 203 185 439 0.347 1 38 408 447 0.045
   Yes 25   54   25 104 0.500 10   65   41 116 0.366 0 12 104 116 0.052
   Ex 25   72   51 148 0.588 20 105   77 202 0.359 0 18 191 209 0.043
Surgery  
   Yes 11   33   26   70 0.607   9   37   35   81 0.340 0   9   74   83 0.054
   No    122 268 178 568 0.549 74 337 274 685 0.354 1 61 638 700 0.045
Only patients with at least 2 years of follow-up from diagnosis were included.
Table 7  Logistic regression analysis
Genes P OR 95% CI
CARD15 2.34E-14 2.908 2.211-3.825
ATG 0.008 1.442 1.099-1.894
ATG (adj CARD15) 0.014 1.439 1.077-1.924
ATG* CARD15 0.692 0.851 0.382-1.894
IL23 0.005 0.613 0.435-0.863
IL23 (adj CARD15) 0.029 0.629 0.414-0.954
IL23* CARD15 0.981 1.010 0.432-2.360
OCTN 0.028 1.434 1.039-1.980
OCTN (adj CARD15) 0.021 1.479 1.061-2.061
TTCC* CARD15 0.632 0.821 0.367-1.839
ATG*IL23*OCTN*CARD15 0.428 0.651 0.226-1.880
Individual contribution of CARD15 (at least 1 variant), ATG16L1 (GG/AG 
vs AA), IL23R rs11209026 (AG/AA vs GG), and OCTN dyploype (TTCC) 
to risk CD. adj CARD15: Contribution from the term after adjustment for 
CARD15 genotype.
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association with any sub-phenotypes. To definitively 
answer this question, studies with a larger cohort of  CD 
are needed to increase the statistical power, particularly 
when considering SNPs that only show a modest 
increase in the odds ratios for susceptibility. Moreover, 
different ethnic populations and true heterogeneity may 
also explain these differences.
IL-23 is a heterodimeric cytokine, composed of  the 
IL-12p40 and p19 subunits. Human and mouse IL-23 
share structural homologies with IL-12, and exhibit 
similar activities, but differ in their capacity to stimulate 
populations of  specific memory T cells, activated to 
produce the proInflammatory mediators IL17 and 
IL16[43]. This so-called TH17 T-cell subset expresses the 
master transcription factor POPγt and mediates chronic 
inflammatory and autoimmune diseases in animal 
models[44]. IL-23 binds with a complex consisting of  IL-
23R and IL-12Rb. IL-23R associates constitutively with 
Jak2 and in a ligand-dependent manner with stat3. The 
human IL-23R gene is on human chromosome 1 within 
150 kb of  IL-12Rb2[45]. It appears that IL-23 plays a 
unique role in the initiation and perpetuation of  innate 
and T cell-mediated forms of  IBD, and variations in the 
early IL-12 and IL-23 dependent regulatory mechanisms 
may impact the subsequent inflammatory response. The 
strong effect of  the protective allele, first identified by 
Duerr et al[15], could potentially be exploited to define 
functional outcomes and targeted therapy that to date 
remain as possibilities.
ATG16L1 is a member of  a large family of  genes 
involved in autophagy, a mechanism by which cells 
recycle redundant organelles, an essential process in the 
resistance to pathogens, targeted for immune evasion by 
viruses and bacteria[46]. The exact functional impact of  
the rs2241880 variant is currently unknown, although 
the ATG16L1 protein is a key component of  autophagy 
and the T300A substitution occurs in an evolutionarily 
conserved domain[32]. The gene is expressed in intestinal 
epithelial cell lines and functional knockdown of  this 
gene abrogates autophagy of  Salmonella typhimurium[16]. 
The important role of  autophagy as predisposing 
factor to CD has recently been highlighted with the 
identification of  variants in immunity-related guanosine 
triphosphatase (IRGM) gene, involved in elimination of  
intracellular bacteria, and susceptibility to CD[47]. How 
this process is implicated in the pathogenesis of  CD 
remains unclear, although it further supports the concept 
of  inflammatory barrier disorder[48].
Our results provide an independent confirmation 
of  the association between the candidate genetic 
variations in IL23R and ATG16L1 genes and CD, 
and reinforce the role of  these new polymorphisms as 
genetic determinants in IBD. Further research is needed 
to understand how IL23R and ATG16L1 variants 
contribute to disease susceptibility in IBD, and whether 
they have therapeutic implications.
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Background 
It is widely accepted that ulcerative colitis (UC) and Crohn’s disease (CD) 
result from an inappropriate response of a defective mucosal immune system 
to indigenous flora and other luminal agents in a genetically susceptible host. 
Eleven inflammatory bowel disease (IBD) genome-wide linkage analyses 
in families with multiple IBD affected members, and two meta-analyses 
have identified several linkage regions. Following the identification of NOD2 
(or CARD15), the first gene contributing to CD susceptibility (IBD1 locus), 
further fine mapping studies have identified a risk haplotype (IBD5 locus) on 
chromosome 5q, and another polymorphism on the disk large homolog 5 (DLG5) 
gene. However, these risk-associated variants and many others reported with 
conflicting results, explain only a minority of the genetic risk in IBD. Whole 
genome association (GWA) studies have rapidly led to the identification of 
novel susceptibility loci such as interleukin-23 receptor (IL23R) and autophagy-
related 16-like 1 gene (ATG16L1).
Research frontiers
An uncommon coding mutation (Arg381Gln) in the IL23R gene has been 
identified as conferring strong protection against CD with ileal involvement. 
Further GWA and replication studies have consistently confirmed strong 
association between variations at IL23R and CD, with a large number of 
replications in adult- and pediatric-onset cohorts, without significant association 
with specific CD sub-phenotype. Moreover, an association with UC has 
also been observed. The non-synonymous (Ala197Thr) variant of ATG16L1 
was found to be associated with CD, but not UC, and has been consistently 
demonstrated in a number of independent studies in adult subjects, but with 
conflicting data in pediatric IBD cohorts.
Innovations and breakthroughs
The present study included a large population of Italian IBD patients (763 
CD and 843 UC), including 368 patients with pediatric onset of disease (age 
at diagnosis < 19 years), 546 healthy parents and 749 healthy controls. All 
patients were accurately phenotyped. Two SNPs of IL23R, one of the ATG16L1, 
and three of the CARD15 genes were genotyped, and were also evaluated for 
interaction with specific clinical features among genes.
Applications
The present study confirms the reported association between IL23R and 
ATG16L1 variants and susceptibility to CD, both in the case-control and family-
based analysis, and both in adult- and pediatric-onset disease. Moreover, we 
also replicated the significant association of the rs11209026 variant of IL23R 
with UC, suggesting that this gene may also have a role in genetic susceptibility 
to UC. Although the size of the cohort was large, consisting of more than 1600 
IBD patients, we were unable to detect an association between IL23R and 
ATG16L1 variants and any sub-phenotypes for both diseases.
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Terminology
GWA is the Genome Wide Association which is examined through a chip 
platform evaluating several thousand SNPs. SNP is Polymorphism of Single 
Nucleotide evaluated to investigate variants of gene probably modifying the 
gene function.
Peer review
This is a nice follow-up study which confirms the association between the 
candidate genetic variations in IL23R/ATG16L1 and IBD, in both pediatric- and 
adult-onset population.
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